Litigation Details for Amgen Inc. v. MSN Laboratories Private Limited (D. Del. 2021)
✉ Email this page to a colleague
Amgen Inc. v. MSN Laboratories Private Limited (D. Del. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-05-06 |
| Court | District Court, D. Delaware | Date Terminated | 2023-11-14 |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | None | Referred To | |
| Parties | AUROBINDO PHARMA USA INC. | ||
| Patents | 10,344,765; 8,377,880; 8,999,932; 9,278,995; 9,701,712; 9,820,938 | ||
| Attorneys | Cortlan S. Hitch | ||
| Firms | Smith, Katzenstein, & Jenkins LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Amgen Inc. v. MSN Laboratories Private Limited
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Biologic Drugs cited in Amgen Inc. v. MSN Laboratories Private Limited
The biologic drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Amgen Inc. v. MSN Laboratories Private Limited (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-05-06 | 1 | Complaint | expiration of U.S. Patent Nos. 9,820,938 (“the ’938 patent”) and 10,344,765 (“the ’765 patent”) (collectively… 1. This is an action for patent infringement under the patent laws of the United States, Title…for its infringement of the ’938 patent. 28. The ’765 patent, titled “Stable Liquid Formulation…the expiration of the ’938 patent is an act of infringement of the ’938 patent under 35 U.S.C. § 271(e)…Aurobindo has knowledge of the ’938 patent at least because the ’938 patent is listed in the FDA’s Orange | External link to document |
| 2022-12-23 | 149 | Notice of Service | Final Validity Contentions for U.S. Patent Nos. 9,820,938, 10,344,765, and 11,165,500 filed by Amgen Inc…Plaintiffs' Final Validity Contentions for U.S. Patent Nos. 8,999,932, 8,377,880, 9,278,995, and 9,701,712… 14 November 2023 1:21-cv-00662 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2021-05-06 | 4 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,820,938 B2; 10,344,765 B2. (kmd) (… 14 November 2023 1:21-cv-00662 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
